-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Entera Bio, Lowers Price Target to $9

Benzinga·04/27/2026 11:43:28
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Entera Bio (NASDAQ:ENTX) with a Buy and lowers the price target from $10 to $9.